Author Archives: sebastian.kostrzynski Kostrzyński

Closed period in connection with Q3 2023 report: 09.10.2023 – 08.11.2023

According to Art. 19 § 11 of the Regulation (EU) No 596/2014 Of The European Parliament And Of The Council of 16 April 2014 on market abuse (market abuse regulation) a person discharging managerial responsibilities within an issuer shall not conduct any transactions on its own account or for the account of a third party, […]

Closed period in connection with H1 2023 report: 19.07.2023 – 18.08.2023

According to Art. 19 § 11 of the Regulation (EU) No 596/2014 Of The European Parliament And Of The Council of 16 April 2014 on market abuse (market abuse regulation) a person discharging managerial responsibilities within an issuer shall not conduct any transactions on its own account or for the account of a third party, […]

Closed period in connection with Q1 2023 report: 08.04.2023 – 08.05.2023

According to Art. 19 § 11 of the Regulation (EU) No 596/2014 Of The European Parliament And Of The Council of 16 April 2014 on market abuse (market abuse regulation) a person discharging managerial responsibilities within an issuer shall not conduct any transactions on its own account or for the account of a third party, […]

Closed period in connection with Annual Report and Consolidated Annual Report for 2022: 21.02.2023 – 23.03.2023

According to Art. 19 § 11 of the Regulation (EU) No 596/2014 Of The European Parliament And Of The Council of 16 April 2014 on market abuse (market abuse regulation) a person discharging managerial responsibilities within an issuer shall not conduct any transactions on its own account or for the account of a third party, […]

Publication of Consolidated Quarterly Report for Q3 2023

Publication of Consolidated Semi-Annual Report for H1 2023

Publication of Consolidated Quarterly Report for Q1 2023

Publication of Annual Report and Consolidated Annual Report for 2022

CR no. 1/2023 – Dates of publication of periodic reports in 2023

CR no. 18/2022 – Information on supervisory assessment (BION/SREP) issued for the Company